The mandatory local agent
No self-filing for foreign manufacturers — the local AR submits to the MOH Central Drug and Medical Devices Department.
Free field guide · PDF
The mandatory local agent, the bilingual label, and the 90–180-day clock — with the class ladder and renewal duties.
Sourced from Kuwait registration guidance and verified 2025–2026 handbooks.
Enter your work email and we'll send the PDF straight to your inbox.
What's inside
Every figure in this guide traces to a named source — Kuwait registration guidance and verified 2025–2026 handbooks.
No self-filing for foreign manufacturers — the local AR submits to the MOH Central Drug and Medical Devices Department.
Class I/II/III risk ladder: 90–180 days typical, 3–6 months for low-risk, up to 9–12 for high-risk — Class III may face clinical-evidence requests.
Arabic + English labeling per MOH, 3–5-year renewal cycles, mandatory adverse-event reporting, and the dossier checklist.
This guide is market-access intelligence, not regulatory or legal advice. KFDHA timelines, fees, and review practice change — professional review is required before business use.
Market Access Strategy Session
A Market Access Strategy Session maps your KFDHA route — local-agent selection, bilingual labeling, and dossier sequencing.
Professional review is required before business use.
Back to ghmap.io Questions? Talk to our team